Drugs (Pharmaceuticals) – Page 46 – MOSAEC

Wegovy, the Weight Loss Drug, Relieves Heart Failure Symptoms: Drugmaker’s Study

Diabetes Drugs (Pharmaceuticals) Heart Mikhail Kosiborod New England Journal of Medicine Novo Nordisk A/S Obesity Placebos Research Semaglutide (Drug) Weight

Wegovy, the Weight Loss Drug, Relieves Heart Failure Symptoms: Drugmaker’s Study

The drug Wegovy eased issues for people with a type of heart problem, adding to the treatment’s benefits beyond weight loss.

By Benjamin Mueller

Mallinckrodt’s Bankruptcy Plan Would Cut Payments to Opioid Victims by $1 Billion

Bankruptcies Compensation for Damages (Law) Drugs (Pharmaceuticals) Mallinckrodt Pharmaceuticals Opioids and Opiates Suits and Litigation (Civil)

Mallinckrodt’s Bankruptcy Plan Would Cut Payments to Opioid Victims by $1 Billion

Mallinckrodt Pharmaceuticals had promised $1.7 billion to governments, individuals and others harmed by the opioid crisis.

By Rebecca Robbins

Expert Panel Recommends New Drugs for HIV Prevention

cabotegravir Descovy Drugs (Pharmaceuticals) Journal of the American Medical Assn Preventive Medicine Sexually Transmitted Diseases Truvada

Expert Panel Recommends New Drugs for HIV Prevention

The “grade A” endorsement means that two additional drugs should be covered under the Affordable Care Act.

By Apoorva Mandavilli

Opioid Settlement Money Is Being Spent on Police Cars and Overtime

Compensation for Damages (Law) Drug Abuse and Traffic Drugs (Pharmaceuticals) Local Government Medicine and Health Opioids and Opiates States (US) Suits and Litigation (Civil)

Opioid Settlement Money Is Being Spent on Police Cars and Overtime

As states and counties spend the first wave of billions of dollars from the pharmaceutical industry, public health groups are challenging how some funds are being used.

By Jan Hoffman